- Home
- XTNT vs DRIO Comparison
XTNT vs DRIO Comparison
Compare XTNT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XTNT | DRIO |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.2M | 84.1M |
| IPO Year | 2009 | 2013 |
Fundamental Metrics
Financial Performance| Metric | XTNT | DRIO |
|---|---|---|
| Price | $0.58 | $11.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 153.6K | 19.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.03 | ★ 9.05 |
| Revenue | ★ $53,337,000.00 | $7,394,000.00 |
| Revenue This Year | $15.08 | N/A |
| Revenue Next Year | N/A | $16.15 |
| P/E Ratio | $19.34 | ★ $1.25 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.34 | $0.38 |
| 52 Week High | $0.95 | $17.74 |
Technical Indicators
Market Signals| Indicator | XTNT | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 51.22 |
| Support Level | $0.55 | $9.30 |
| Resistance Level | $0.68 | $11.40 |
| Average True Range (ATR) | 0.03 | 0.70 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 29.09 | 64.02 |
Price Performance
Historical ComparisonAbout XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.